ClinicalTrials.gov
ClinicalTrials.gov Menu

Delirium in Mechanically Ventilated Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00919698
Recruitment Status : Completed
First Posted : June 12, 2009
Last Update Posted : December 3, 2014
Sponsor:
Information provided by (Responsible Party):
University of Chicago

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The overall purpose of this trial is to assess the relationship between a daily awakening from sedation and the prevalence of delirium, and in doing so better characterize delirium in the ICU.

Condition or disease
Delirium

Detailed Description:
This is a single center, observational, cross-over design study assessing the impact of daily awakening from sedation on delirium in the ICU. Enrolled patients will receive a daily baseline delirium assessment using the CAM-ICU tool before the awakening from sedation and an assessment during the awakening from sedation. Each patient will thus serve as their own controls for these interventions.

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Actual Enrollment : 102 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: An Assessment of Delirium in Mechanically Ventilated Patients Undergoing Daily Awakening From Sedation
Study Start Date : June 2010
Actual Primary Completion Date : October 2013
Actual Study Completion Date : October 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Delirium
U.S. FDA Resources

Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
Sedated mechanically ventilated patients


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Delirium [ Time Frame: Daily ]

Secondary Outcome Measures :
  1. ICU admitting diagnosis [ Time Frame: At enrollment ]
  2. Medications [ Time Frame: Daily ]
  3. Ventilator free days (or first 28) [ Time Frame: At 28 days post-intubation ]
  4. ICU complications [ Time Frame: Daily ]
  5. Days to discharge [ Time Frame: At discharge ]
  6. Survival [ Time Frame: At discharge ]

Other Outcome Measures:
  1. survival [ Time Frame: 1 year ]
  2. institution free days [ Time Frame: 1 year ]

Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Adult patients (> 18 years old) admitted to the intensive care unit who require mechanical ventilation through an endotracheal tube with infusion of sedative or analgesic medication.
Criteria

Inclusion Criteria:

  • > 18 years old
  • intubated and mechanically ventilated
  • receiving sedative and/or analgesic medication
  • candidate for daily awakening from sedative and/or analgesic medication

Exclusion Criteria:

  • primary neurologic disease (stroke, seizure, elevated ICP)
  • post cardiac arrest
  • do not speak English (assessment only English language validated)
Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00919698


Locations
United States, Illinois
The University of Chicago
Chicago, Illinois, United States, 60637
Sponsors and Collaborators
University of Chicago
Investigators
Principal Investigator: John P Kress, MD University of Chicago
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: University of Chicago
ClinicalTrials.gov Identifier: NCT00919698     History of Changes
Other Study ID Numbers: 16938B
First Posted: June 12, 2009    Key Record Dates
Last Update Posted: December 3, 2014
Last Verified: December 2014

Keywords provided by University of Chicago:
Hypnotics and Sedatives
Respiration, Artificial
Ventilators, Mechanical
Critical care
Intensive care

Additional relevant MeSH terms:
Delirium
Confusion
Neurobehavioral Manifestations
Neurologic Manifestations
 Nervous System Diseases
Signs and Symptoms
Neurocognitive Disorders
Mental Disorders